Renaissance Technologies Increases Stake in Xtant Medical
1 report, 1 independent
Updated Sep 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Renaissance Technologies increased its financial stake in Xtant Medical on September 1, 2026. The medical device company reported revenue of $23.03 million for the quarter, missing consensus estimates of $24.88 million. The company reported earnings per share of negative $0.07, missing expectations of negative $0.02. The company's market capitalization stood at $52.71 million.
From themarketsdaily.com
Why it matters
The stake increase by Renaissance Technologies adds to the market scrutiny of Xtant Medical. The company is currently facing a decline in short interest, which dropped 85.3% to 268,742 shares as of September 15th. Xtant Medical's stock traded at $0.38 on the day of the report.
From themarketsdaily.com
Who's involved
- Renaissance TechnologiesAmerican hedge fund firm that increased its financial stake in Xtant Medical.